US20030075189A1 - Protein based smoking cessation gel for application to a smoking article - Google Patents
Protein based smoking cessation gel for application to a smoking article Download PDFInfo
- Publication number
- US20030075189A1 US20030075189A1 US10/037,848 US3784801A US2003075189A1 US 20030075189 A1 US20030075189 A1 US 20030075189A1 US 3784801 A US3784801 A US 3784801A US 2003075189 A1 US2003075189 A1 US 2003075189A1
- Authority
- US
- United States
- Prior art keywords
- composition
- smoking article
- protein
- cigarette
- mouthpiece
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 230000000391 smoking effect Effects 0.000 title claims abstract description 37
- 102000004169 proteins and genes Human genes 0.000 title claims abstract description 21
- 108090000623 proteins and genes Proteins 0.000 title claims abstract description 21
- 230000005586 smoking cessation Effects 0.000 title description 6
- UGFAIRIUMAVXCW-UHFFFAOYSA-N Carbon monoxide Chemical compound [O+]#[C-] UGFAIRIUMAVXCW-UHFFFAOYSA-N 0.000 claims abstract description 35
- 229910002091 carbon monoxide Inorganic materials 0.000 claims abstract description 34
- 239000000203 mixture Substances 0.000 claims abstract description 30
- 238000000034 method Methods 0.000 claims abstract description 22
- 235000019504 cigarettes Nutrition 0.000 claims description 34
- 239000012530 fluid Substances 0.000 claims description 20
- 239000007788 liquid Substances 0.000 claims description 20
- 239000000779 smoke Substances 0.000 claims description 20
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid group Chemical group C(CC(O)(C(=O)O)CC(=O)O)(=O)O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims description 15
- 239000000499 gel Substances 0.000 claims description 13
- 239000003795 chemical substances by application Substances 0.000 claims description 9
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims description 8
- 239000001301 oxygen Substances 0.000 claims description 8
- 229910052760 oxygen Inorganic materials 0.000 claims description 8
- 239000006188 syrup Substances 0.000 claims description 7
- 235000020357 syrup Nutrition 0.000 claims description 7
- 235000013305 food Nutrition 0.000 claims description 6
- 230000007423 decrease Effects 0.000 claims description 5
- IBPDKUYWDGDBQW-UHFFFAOYSA-N (1-hydroxy-3-phosphonooxypropan-2-yl) dihydrogen phosphate Chemical group OP(=O)(O)OC(CO)COP(O)(O)=O IBPDKUYWDGDBQW-UHFFFAOYSA-N 0.000 claims description 4
- 102000008015 Hemeproteins Human genes 0.000 claims description 3
- 108010089792 Hemeproteins Proteins 0.000 claims description 3
- 102000010750 Metalloproteins Human genes 0.000 claims description 3
- 108010063312 Metalloproteins Proteins 0.000 claims description 3
- 235000019506 cigar Nutrition 0.000 claims description 3
- 239000003921 oil Substances 0.000 claims description 3
- 231100000419 toxicity Toxicity 0.000 claims description 2
- 230000001988 toxicity Effects 0.000 claims description 2
- 235000018102 proteins Nutrition 0.000 claims 6
- 235000004252 protein component Nutrition 0.000 claims 5
- 108090000035 Pseudoazurin Proteins 0.000 claims 2
- 108091009123 carbon monoxide binding proteins Proteins 0.000 claims 2
- 230000000087 stabilizing effect Effects 0.000 claims 2
- SNICXCGAKADSCV-JTQLQIEISA-N (-)-Nicotine Chemical compound CN1CCC[C@H]1C1=CC=CN=C1 SNICXCGAKADSCV-JTQLQIEISA-N 0.000 abstract description 13
- 229960002715 nicotine Drugs 0.000 abstract description 13
- SNICXCGAKADSCV-UHFFFAOYSA-N nicotine Natural products CN1CCCC1C1=CC=CN=C1 SNICXCGAKADSCV-UHFFFAOYSA-N 0.000 abstract description 13
- 239000000047 product Substances 0.000 description 12
- 239000011269 tar Substances 0.000 description 10
- 239000000463 material Substances 0.000 description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 8
- 102000001554 Hemoglobins Human genes 0.000 description 6
- 108010054147 Hemoglobins Proteins 0.000 description 6
- 230000009467 reduction Effects 0.000 description 6
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 4
- 241000208125 Nicotiana Species 0.000 description 4
- 235000002637 Nicotiana tabacum Nutrition 0.000 description 4
- 239000002775 capsule Substances 0.000 description 4
- 229920000742 Cotton Polymers 0.000 description 3
- 230000004888 barrier function Effects 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 210000003754 fetus Anatomy 0.000 description 3
- 239000004033 plastic Substances 0.000 description 3
- 230000035935 pregnancy Effects 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- XOHUEYCVLUUEJJ-UHFFFAOYSA-N 2,3-Bisphosphoglyceric acid Chemical compound OP(=O)(O)OC(C(=O)O)COP(O)(O)=O XOHUEYCVLUUEJJ-UHFFFAOYSA-N 0.000 description 2
- CHHHXKFHOYLYRE-UHFFFAOYSA-M 2,4-Hexadienoic acid, potassium salt (1:1), (2E,4E)- Chemical compound [K+].CC=CC=CC([O-])=O CHHHXKFHOYLYRE-UHFFFAOYSA-M 0.000 description 2
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
- 230000002745 absorbent Effects 0.000 description 2
- 239000002250 absorbent Substances 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 230000006835 compression Effects 0.000 description 2
- 238000007906 compression Methods 0.000 description 2
- 238000009833 condensation Methods 0.000 description 2
- 230000005494 condensation Effects 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 238000010494 dissociation reaction Methods 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 239000007789 gas Substances 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 235000011187 glycerol Nutrition 0.000 description 2
- 230000005802 health problem Effects 0.000 description 2
- 230000008450 motivation Effects 0.000 description 2
- 210000002826 placenta Anatomy 0.000 description 2
- 229940069338 potassium sorbate Drugs 0.000 description 2
- 235000010241 potassium sorbate Nutrition 0.000 description 2
- 239000004302 potassium sorbate Substances 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 241000208140 Acer Species 0.000 description 1
- 208000006096 Attention Deficit Disorder with Hyperactivity Diseases 0.000 description 1
- 208000036864 Attention deficit/hyperactivity disease Diseases 0.000 description 1
- 206010012335 Dependence Diseases 0.000 description 1
- 241001539473 Euphoria Species 0.000 description 1
- 206010015535 Euphoric mood Diseases 0.000 description 1
- 206010053759 Growth retardation Diseases 0.000 description 1
- 208000032754 Infant Death Diseases 0.000 description 1
- 208000036626 Mental retardation Diseases 0.000 description 1
- 108010062374 Myoglobin Proteins 0.000 description 1
- 102000036675 Myoglobin Human genes 0.000 description 1
- 208000020241 Neonatal disease Diseases 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 208000034972 Sudden Infant Death Diseases 0.000 description 1
- 206010042440 Sudden infant death syndrome Diseases 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- NFFWXKMYRADDOZ-UHFFFAOYSA-N [C].N1=CC=CC(=C1)C1N(C)CCC1 Chemical compound [C].N1=CC=CC(=C1)C1N(C)CCC1 NFFWXKMYRADDOZ-UHFFFAOYSA-N 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- 208000015802 attention deficit-hyperactivity disease Diseases 0.000 description 1
- 231100000871 behavioral problem Toxicity 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 210000000601 blood cell Anatomy 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 230000006931 brain damage Effects 0.000 description 1
- 231100000874 brain damage Toxicity 0.000 description 1
- 208000029028 brain injury Diseases 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 230000000711 cancerogenic effect Effects 0.000 description 1
- 231100000315 carcinogenic Toxicity 0.000 description 1
- 210000000748 cardiovascular system Anatomy 0.000 description 1
- 201000002797 childhood leukemia Diseases 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 238000002485 combustion reaction Methods 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 235000005687 corn oil Nutrition 0.000 description 1
- 239000002285 corn oil Substances 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 230000005593 dissociations Effects 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 201000003511 ectopic pregnancy Diseases 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 230000001605 fetal effect Effects 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000013355 food flavoring agent Nutrition 0.000 description 1
- 231100000001 growth retardation Toxicity 0.000 description 1
- 150000003278 haem Chemical group 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 231100000206 health hazard Toxicity 0.000 description 1
- 208000019622 heart disease Diseases 0.000 description 1
- 235000012907 honey Nutrition 0.000 description 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
- 208000035231 inattentive type attention deficit hyperactivity disease Diseases 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- 239000012263 liquid product Substances 0.000 description 1
- 231100000533 low birth weight Toxicity 0.000 description 1
- 208000018773 low birth weight Diseases 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 239000002480 mineral oil Substances 0.000 description 1
- 235000010446 mineral oil Nutrition 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 230000035772 mutation Effects 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 235000019198 oils Nutrition 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 235000010987 pectin Nutrition 0.000 description 1
- 239000001814 pectin Substances 0.000 description 1
- 229920001277 pectin Polymers 0.000 description 1
- 208000015754 perinatal disease Diseases 0.000 description 1
- 235000019271 petrolatum Nutrition 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 230000007096 poisonous effect Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 208000023504 respiratory system disease Diseases 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 239000003549 soybean oil Substances 0.000 description 1
- 235000012424 soybean oil Nutrition 0.000 description 1
- 208000000995 spontaneous abortion Diseases 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
- A24D—CIGARS; CIGARETTES; TOBACCO SMOKE FILTERS; MOUTHPIECES FOR CIGARS OR CIGARETTES; MANUFACTURE OF TOBACCO SMOKE FILTERS OR MOUTHPIECES
- A24D3/00—Tobacco smoke filters, e.g. filter-tips, filtering inserts; Filters specially adapted for simulated smoking devices; Mouthpieces for cigars or cigarettes
- A24D3/06—Use of materials for tobacco smoke filters
- A24D3/14—Use of materials for tobacco smoke filters of organic materials as additive
Landscapes
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Materials Engineering (AREA)
- Cigarettes, Filters, And Manufacturing Of Filters (AREA)
Abstract
A protein-based composition for application to the mouth end of a smoking article to reduce the amount of carbon monoxide, tar and nicotine inhaled by a smoker. Also disclosed is a method for the cessation of smoking by applying the protein-based compostion to the mouth end of a smoking article.
Description
- This invention relates to the tobacco art, and more particularly, to a smoking cessation product comprising a protein for binding carbon monoxide and a fluid/gel base that is applied to a smoking article and that reduces the amount of carbon monoxide, tar and nicotine that is inhaled by a smoker.
- There have been attempts to design tar and nicotine reducing elements for tobacco smoke described in the prior art and several of these elements contain means for moistening or humidifying a porous filter. Typically, a frangible module containing water or an aqueous solution is embedded in the filter and the module is compressed to release the liquid before the filter is used. The moistened filter material in the element then exhibits an improved ability to remove the primary tars and nicotine.
- For example, in U.S. Pat. No. 3,884,246, to Eric E. Walker, a tobacco smoke filter element comprised of a resilient, water impervious elongated tubular casing having a porous plug of filtering material disposed in each end of said casing; opposed, mutually spaced, disc-like walls disposed within said casing between said plugs, one wall within said casing between said plugs and one wall abutting the inner surface of each plug, said walls defining a chamber within the central portion of said casing and having at least one port in each wall. The device further includes at least one liquid containing module disposed within said chamber and extending between said walls, wherein said walls have at least one passage for allowing smoke through said filter element and means carried by said element and cooperating between said module and at least one port in each of said walls for directing liquid from said module through the ports into said plugs responsive to compression of the external walls of said chamber so that said plugs may act selectively as a dry filter, or when said casing is compressed, as a filter moistened by said liquid.
- In U.S. Pat. No. 3,428,049 to Leake et al., one or more modules are surrounded by a compressed filter material in the element. When the module is compressed, the liquid saturates the filter material causing it to expand into the space occupied by the module. It is made as part of the cigarette, confined to the filter.
- In U.S. Pat. No. 3,635,226 to Horsewell et al. a liquid-containing capsule is disposed between an absorbent plug, adjacent the tobacco, and a nonabsorbent plug such that when the capsule is compressed the liquid is released into the absorbent plug. U.S. Pat. No. 3,596,665 to Lundegard also describes a frangible, liquid containing module disposed between two plugs. Compression of this module releases the liquid into both plugs for enhanced filtering.
- In addition, many different liquids have been encapsulated within the filter mechanism of smoking articles to moisten the filters. Examples thereof are water, glycerin, and aqueous solutions or emulsions containing aromatic flavoring agents. These liquids act, in the filter, primarily to cool the smoke and to facilitate condensation of volatile components therein on the filter substrate.
- The above described filters describe smoke filters containing collapsible or frangible capsules filled with water or other liquids. Filter elements containing liquid pose a problem of retaining the liquid during storage, and those containing capsules or other containers of a liquid often present within the filter structure cause a problem when the liquid is released as the liquid holds the filter element in a collapsed state after pressure on filter has been released.
- Thus, the aforementioned prior art filters lack the desired versatility necessary for widespread acceptance.
- In the above described products, the liquid products were incorporated inside the filter or made as an attachment to the filter.
- U.S. Pat. Nos. 4,003,387, 4,046,153 and 3,797,644, are directed to, AquaFilter, a disposable cigarette holder made of plastic, which has a wet cotton filter on the inside. The wetness in the cotton filter is glycerin and water. The holder is attached to the mouth end of a cigarette through which smoke is drawn into and over the wet cotton filter, held together by plastic casing, into a smoker's mouth. This caused the smoke to condensate tar and nicotine (total particular matter) on to the fiber wet filter. Most smokers, however, object to having a foreign object, such as a plastic attachment in their mouth.
- As a practical matter, the process of manufacturing and packaging cigarettes and the necessity for storing cigarettes of varying periods of time, have proven to be affected because of damage to filter, drying out, impact or disfiguring of the filter with moisture before being smoked.
- Another example, in U.S. Pat. No. 3,319,632 to Henry Burbig, relates to a cigarette moistener device. In this device the interior of the filter tip of a cigarette is moistened. The device is topped by a receptacle and is provided with a hollow needle extending axially thereof, wherein the needle has a number of openings in the side thereof and the hollow needle extends into the moistener container. Where the moistener container is a squeeze bottle with resilient side, the insertion of the filter into the receptacle and squeezing the sides of the moistener container will result in impregnating the inner part of the filter with moisture The utilization of a hollow needle of greatly restricted diameter will meter the amount of moisture thus expressed on a single squeeze, to impregnate the interior of the cigarette filter with water.
- In U.S. Pat. Nos. 5,158, 099 and 5, 240,015 to Rosen et al, the invention is a wetted impact barrier that is applied to the surface of a cigarette filter. This product has the ability to remove nicotine and tar. This solution does not remove carbon monoxide from the smoke.
- However, none of the above products/inventions are suitable for removing carbon monoxide gas from the cigarette smoke. Therefore, they are ineffective in treating smoking addiction.
- Carbon monoxide (CO) is a poisonous gas that reduces the bloods ability to transport oxygen around the body. It is present in quantity in cigarette and smoke. As it reduces the body's oxygen carrying ability, the heart is required to beat faster to compensate for the lack of oxygenated blood. This leads to heart disease and strokes—the biggest killer of smokers. Traditionally, quit smoking solutions, such as those mentioned above, have concentrated on nicotine removal, as nicotine is a chemical that makes smoking addictive. However, this may not be the only addictive aspect of cigarette smoke. Increased heart rate due to CO stimulates the smoker, and thus makes the activity of smoking more enjoyable and reinforces the desire to smoke. In addition, CO is responsible for reducing the flow of oxygen and nutrients through the placenta to a developing fetus and is therefore a major health risk when a pregnant woman smokes.
- In 1995, approximately 14 percent of women smoked during pregnancy down 5 percent from 1994 and 29 percent since 1989. Despite the decline, smoking prevalence among pregnant women still exceeds the Healthy People 2000 objective to reduce smoking by pregnant women to 10 percent (Center for Disease Control—Fact Sheet on Smoking and Pregnancy, http://www.cdc.gov/od/oc/media/fact/smokpreg.htm). Numerous scientific studies have established that smoking by pregnant women, or their regular exposure to secondhand smoke, dramatically increases the risk of a range of health problems both to themselves and their offspring, including the following: spontaneous abortions, ectopic pregnancies, other birth and delivery problems, fetal brain damage, growth retardation/low birth weight, lower or higher than normal infant blood pressure (depending on gestational age at delivery), problems requiring neonatal intensive care, infant death from perinatal disorders, sudden infant death syndrome, cancer-causing agents in infant's blood, potentially carcinogenic genetic mutations, childhood leukemia, mental retardation, respiratory disorders during childhood, eye problems during childhood, Attention Deficit Disorder, other learning and developmental problems, behavioral problems, violence, and criminality, smoking during adolescence and various adult health problems.
- Thus, there is a major need for a product that reduces the toxicity of smoking articles and aids in the cessation of smoking.
- The invention is a smoking cessation product which utilizes proteins that bind carbon monoxide. The proteins are integrated with a base fluid to form a combined gel. When applied to the filter of a cigarette, the combined gel has the ability to remove or reduce the nicotine, tar and carbon monoxide levels in the cigarette smoke.
- Using a protein to trap carbon monoxide (CO) reduces the effect that CO has on the smoker. Specifically, a smoker's blood cells will not become saturated to the same degree with CO, (forming carboxyhaemoglobin) which will lead to a reduced burden on the cardiovascular system. In addition, a decrease in carboxyhaemoglobin levels leads to a reduction in a smoker's heart rate and this in turn reduces the feeling of euphoria that smokers receive when smoking. Since increased heart rate induced by CO reinforces the psychological and physiological motivation to smoke, a reduction of CO and thus heart rate reduces the motivation to smoke and results in a better, more effective, smoking cessation product.
- Cessation of smoking and the reduction of CO, tar and nicotine in cigarettes provides a major advantage to women who smoke during pregnancy. CO crosses the placenta barrier and is a major health hazard to the unborn fetus. Other smoking cessation compositions that allow the smoker to continue smoking while they are attempting to quit nevertheless expose the fetus to potential CO harm. Utiilzing this present invention, pregnant smokers can still continue to smoke while undergoing nicotine withdrawal treatment and the CO effect on the infant is reduced.
- The details of one or more embodiments of the invention are set forth in the accompanying description below. Although any methods and materials similar or equivalent to those described herein can be used in the practice or testing of the present invention, the preferred methods and materials are now described. Other features, objects, and advantages of the invention will be apparent from the description. In the specification and the appended claims, the singular forms also include the plural unless the context clearly dictates otherwise. Unless defined otherwise, all technical and scientific terms used herein have the same meaning as commonly understood by one of ordinary skill in the art to which this invention belongs. All patents and publications cited in this specification are incorporated herein by reference.
- The smoking cessation product comprises a composition that is applied to the mouth end of a smoking article. Various proteins can be used in this invention, for example, Heme proteins, such as Hemoglobin and Myoglobin and proteins containing a Heme group; Blue Copper Proteins, Metalloproteins and CooA protein. In a preferred embodiment, Hemoglobin is used. The invention is not limited however, to these proteins and any protein that attracts or binds with carbon monoxide (CO) can be used.
- Alongside the protein, a control agent/chemical can be used to decrease the affinity of the protein to bind with oxygen and facilitate the binding of CO. As a non-limiting example, 2,3 diphosphoglycerine is used alongside Hemoglobin to shift the oxygen-dissociation balance from oxygen to CO.
- In addition, the pH levels of the combined gel can be maintained in a stable range, facilitating the dissociation of oxygen in favor of CO. Citric acid, in varying amounts depending upon the composition of the gel/fluid, can be used to moderate the pH value.
- A gel/fluid base component of the invention can be made from syrup-type solutions, such as; corn syrups, honey, glycol, petroleum jelly, mineral oil, maple syrup. In addition, any sugar base liquids, such as; all fruit syrups, gur-gum, may also be used. Further, all food grade oils, such as; soybean oil, corn oil, pectin and food grade gels may be used. The base component acts when applied physically by the user on the top surface of the mouthpiece of all filter types, primarily acts as a barrier, when smoked, causing impact, cooling of the smoke and facilitating condensation of nicotine and tar compounds which are able to be seen on the top surface of mouthpiece of cigarettes.
- The composition is not part of a cigarette or cigarette rod. Only when the fluid is applied physically onto the top surface of the filter mouthpiece of the cigarette does it become part of the filter. The gel/fluid is made in a clean environment and mixed utilizing normal machinery, though methodologies may vary. The fluid can be colored so that one can see where the fluid is being applied to the top surface of filter mouthpiece. The gel/fluid base has a viscosity to coat the end of a cigarette wherein the coating or composition placed on the end of the cigarette being of sufficient amount to reduce the tar and nicotine and CO produced from the combustion of said product.
- Although the invention has hereto before been described with regard to use with and application to cigarettes, the composition is also contemplated for use with and application to other smoking articles, such as cigars. The composition can be dispensed onto the filter using a squeezable container having a dispenser, or via a pipette which can be inserted into the container to draw an amount of the composition for application to the filter. In addition to this, any suitable container could be used to dispense the fluid onto the surface of the filter.
- The invention is further defined by reference to the following examples. It will be apparent to those skilled in the art that many modifications, both to the materials and methods, may be practiced without departing from the purpose and interest of the invention.
- For example, one representation of the product is Hemoglobin protein, 2,3 diphosphoglycerine (2,3 DPG), glucose syrup, water, citric acid, sodium benzorate and potassium sorbate, where Hemoglobin binds CO as it passes through the filter, 2,3 DPG increases the affinity of Hemoglobin towards CO, glucose syrup and water act as a cooling and condensing agent and add viscosity to the product, citric acid maintains an appropriate pH level and sodium benzorate and potassium sorbate stabilize the entire product.
- Two brands of cigarettes (Silk Cut and Rothmans) were treated with the combined compound described above by applying three drops of the compound onto the top surface of mouthpiece onto the filter material before being smoked utilizing a squeeze bottle dispenser. The cigarettes were then smoked on a cigarette smoking machine according to the Cambridge method approved and utilized by the F.T.C. Another group Silk Cut and Rothman cigarettes were smoked on the cigarette smoking machine, as is (without the composition). Using the above defined combination composition provided the following results:
Brand of Nicotine Carbon Cigarette Reduction Tar Reduction Monoxide Reduction Silk Cut 97.1% 98.9% 88.5% Rothmans 98.0% 99.4% 91.1%
Claims (28)
1. A composition for application to a mouthpiece of a smoking article for reducing the toxicity of the smoking article, comprising a protein component for binding carbon monoxide, a base fluid component, and a control agent to facilitate the binding of the carbon monoxide and to decrease the affinity of the protein to bind with oxygen.
2. The composition of claim 1 , wherein the protein may be selected from the group consisting of heme proteins, blue copper proteins, metalloproteins, CooA proteins and carbon monoxide binding proteins.
3. The composition of claim 1 , wherein the control agent is 2,3-diphosphoglycerine.
4. The composition of claim 1 , further comprising a pH control element and one or more stabilizing elements.
5. The composition of claim 4 , wherein the pH control element is citric acid.
6. The composition of claim 1 , wherein the protein component and the control agent are mixed with the base fluid component to form a gel.
7. The composition of claim 6 , wherein the fluid component may be selected from the group consisting of syrup-based solutions, sugar-based liquids, food grade oils and food grade gels.
8. The composition of claim 1 , wherein said composition resides in a container having a dispenser to facilitate application to the mouthpiece of the smoking article.
9. The composition of claim 8 , wherein said container is a squeezable container.
10. The composition of claim 8 , wherein said container is provided with a pipette.
11. The composition of claim 1 , wherein the base fluid component is colored to identify application to the mouthpiece of the cigarette.
12. The composition of claim 1 , wherein the base fluid component is viscous for application to the mouthpiece of the cigarette.
13. The composition of claim 1 , wherein the smoking article is a cigarette.
14. The composition of claim 1 , wherein the smoking article is a cigar.
15. A method for the cessation of smoking, the method comprising:
applying a composition to the mouthpiece of a smoking article prior to igniting said smoking article, the composition comprising a protein component for binding carbon monoxide and a control agent to facilitate the binding of the carbon monoxide and to decrease the affinity the protein to bind with oxygen and a base fluid component; and
igniting said smoking article, wherein the protein component in the composition traps carbon monoxide from smoke generated in the smoking article via the inhalation by a smoker.
16. The method of claim 15 , wherein the protein may be selected from the group consisting of heme proteins, blue copper proteins, metalloproteins, CooA proteins and other carbon monoxide binding proteins.
17. The method of claim 15 , wherein the control agent is 2,3-diphosphoglycerine.
18. The method of claim 15 , further comprising a pH control element and one or more stabilizing elements.
19. The method of claim 18 , wherein the pH control element is citric acid.
20. The method of claim 15 , wherein the protein component and the control agent are mixed with the base fluid component to form a gel.
21. The method of claim 20 , wherein the fluid component may be selected from the group consisting of syrup-based solutions, sugar-based liquids, food grade oils and food grade gels.
22. The method of claim 15 , wherein said composition resides in a container having a dispenser to facilitate application to the mouthpiece of the smoking article.
23. The method of claim 22 , wherein said container is a squeezable container.
24. The method of claim 22 , wherein said container is provided with a pipette.
25. The method of claim 15 , wherein the base fluid component is colored to identify application to the mouthpiece of the cigarette.
26. The method of claim 15 , wherein the base fluid component is viscous for application to the mouthpiece of the cigarette.
27. The method of claim 15 , wherein the smoking article is a cigarette.
28. The method of claim 15 , wherein the smoking article is a cigar.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US10/037,848 US20030075189A1 (en) | 2001-10-19 | 2001-10-19 | Protein based smoking cessation gel for application to a smoking article |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US10/037,848 US20030075189A1 (en) | 2001-10-19 | 2001-10-19 | Protein based smoking cessation gel for application to a smoking article |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| US20030075189A1 true US20030075189A1 (en) | 2003-04-24 |
Family
ID=21896701
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| US10/037,848 Abandoned US20030075189A1 (en) | 2001-10-19 | 2001-10-19 | Protein based smoking cessation gel for application to a smoking article |
Country Status (1)
| Country | Link |
|---|---|
| US (1) | US20030075189A1 (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20080230078A1 (en) * | 2007-03-19 | 2008-09-25 | Oby George Tolman | Method of smoking cessation |
-
2001
- 2001-10-19 US US10/037,848 patent/US20030075189A1/en not_active Abandoned
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20080230078A1 (en) * | 2007-03-19 | 2008-09-25 | Oby George Tolman | Method of smoking cessation |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR930005444B1 (en) | Nicotine injector | |
| US4793366A (en) | Nicotine dispensing device and methods of making the same | |
| US2755206A (en) | Tobacco smoking article | |
| JP5068137B2 (en) | Filtered cigarettes incorporating adsorbent materials | |
| US20100200008A1 (en) | E-Cigarette With Vitamin Infusion | |
| JP5886823B2 (en) | Suppression of undesirable sensory effects by synthetic camphor | |
| US4655231A (en) | Snuff and preparation thereof | |
| BRPI0813791B1 (en) | multi-component filter for a smoking article | |
| UA100076C2 (en) | Filter element for a smoking article, the smoking article comprising the filter element, a method for making the filter element and a thread for the filter element | |
| US20100300466A1 (en) | Smoking Accessory | |
| US20100236052A1 (en) | Device and method for forming a barrier to a smoking article | |
| EA008885B1 (en) | Filter cigarette | |
| JPS5917974A (en) | Smoking articles and filters for smoking articles | |
| JP3661131B2 (en) | Smoking suppression device | |
| US20030075189A1 (en) | Protein based smoking cessation gel for application to a smoking article | |
| RU96108402A (en) | FILTER-CURED VENTILATION CIGARETTE | |
| EP4266910A1 (en) | A pouched product for oral use comprising a particulate filling material | |
| US5158099A (en) | Wetted impact barrier for the reduction of tar and nicotine in cigarette smoke | |
| US5240015A (en) | Wetted impact barrier for the reduction of tar and nicotine in cigarette smoke | |
| IE83914B1 (en) | Wetted impact barrier for the reduction of tar and nicotine in cigarette smoke | |
| US2408481A (en) | Cigarette conditioner | |
| EP0450253B1 (en) | Means for breaking the habitual use of tobacco | |
| KR20230125189A (en) | Oral pouch product comprising a liquid permeable covering material and a filling material | |
| JPS6133911Y2 (en) | ||
| JPH09121832A (en) | Healthy auxiliary tool for no smoking of cigarette type |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |